Bacil Pharma Ltd (NSE: BACPHAR), ISIN INE711D01018 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
BACPHAR last traded at ₹24.19 (-4.99%), with a 52-week range of ₹24.19 to ₹61.80 (as of 30 Jul 2026).
Shareholding as of Dec 2025: promoters 0.08%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 9/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.